Asia Pacific Fabry Disease Treatment Market Size Growth Boosted by ERT Use
Market Overview The Asia Pacific Fabry Disease Treatment Market is witnessing steady expansion as healthcare systems across the region improve rare disease diagnosis, expand access to advanced biologics, and increase awareness of lysosomal storage disorders. Fabry disease is a rare X-linked genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of...
0 Comments 0 Shares 11 Views 0 Reviews